[HTML][HTML] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
Introduction The World Health Organization (WHO) recommends that human papillomavirus
(HPV) vaccination programs are established to be cost-effective before implementation …
(HPV) vaccination programs are established to be cost-effective before implementation …
[HTML][HTML] Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a …
Background First generation bivalent and quadrivalent human papillomavirus (HPV)
vaccines have been introduced in most developed countries. A next generation nonavalent …
vaccines have been introduced in most developed countries. A next generation nonavalent …
[HTML][HTML] The prevalence of cervical human papillomavirus infection and the most at-risk genotypes among Iranian healthy women: A systematic review and meta …
M Malary, M Moosazadeh… - … journal of preventive …, 2016 - journals.lww.com
Background: One of the most common sexual-transmitted infections among women is
human papillomavirus (HPV) infection which is associated with genital cancers. Different …
human papillomavirus (HPV) infection which is associated with genital cancers. Different …
Effect of human papillomavirus vaccination on cervical cancer screening in Alberta
J Kim, C Bell, M Sun, G Kliewer, L Xu, M McInerney… - Cmaj, 2016 - Can Med Assoc
Background: A school-based program with quadrivalent human papillomavirus (HPV)
vaccination was implemented in Alberta in 2008. We assessed the impact of this program on …
vaccination was implemented in Alberta in 2008. We assessed the impact of this program on …
HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States
S Hariri, ER Unger, S Schafer, LM Niccolai… - … Biomarkers & Prevention, 2015 - AACR
Background: Two currently available vaccines targeting human papillomavirus (HPV) types
16 and 18 could prevent 70% of cervical cancers and 50% of high-grade cervical lesions …
16 and 18 could prevent 70% of cervical cancers and 50% of high-grade cervical lesions …
[HTML][HTML] HPV vaccination adherence in working-age men: a systematic review and meta-analysis
C Amantea, N Foschi, F Gavi, I Borrelli, MF Rossi… - Vaccines, 2023 - mdpi.com
Background: Human papillomavirus (HPV) infection is the most common sexually
transmitted viral infection in the world. HPV vaccination adherence rates in men are …
transmitted viral infection in the world. HPV vaccination adherence rates in men are …
HPV vaccine: Current status and future directions
HPV Vaccine was introduced to prevent cervical cancer known to be caused by infection
with one or more of the high risk subtypes of the Human papilloma virus (HPV). Since …
with one or more of the high risk subtypes of the Human papilloma virus (HPV). Since …
Evaluation of type replacement following HPV16/18 vaccination: pooled analysis of two randomized trials
Background: Current HPV vaccines do not protect against all oncogenic HPV types.
Following vaccination, type replacement may occur, especially if different HPV types …
Following vaccination, type replacement may occur, especially if different HPV types …
Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines
TR Buchanan, WS Graybill… - Human Vaccines & …, 2016 - Taylor & Francis
Vaginal and vulvar cancers do not account for a large proportion of gynecologic
malignancies but their impact is significant. Both vaginal and vulvar lesions have precursors …
malignancies but their impact is significant. Both vaginal and vulvar lesions have precursors …
[HTML][HTML] Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
A Zacharia, E Harberts, SM Valencia, B Myers… - Vaccine, 2021 - Elsevier
Current human papilloma virus (HPV) vaccines provide substantial protection against the
most common HPV types responsible for oral and anogenital cancers, but many circulating …
most common HPV types responsible for oral and anogenital cancers, but many circulating …